Research Paper Volume 15, Issue 11 pp 4757—4773
Knocking down NSUN5 inhibits the development of clear cell renal cell carcinoma by inhibiting the p53 pathway
Figure 4. Distinct TME characteristics of ccRCC patients according to the risk score. (A) Boxplots showed abundance of 22 infiltrating immune cell types. (B) Correlation between nine immune cells and patient risk score. (C) Lollipop plot showed abundance of 22 infiltrating immune cell types. (D) Immune function differential analysis for single sample gene set enrichment analysis. (E) Kaplan-Meier curves for the 9 immune function in ccRCC patients (*P < 0.05, **P < 0.01, ***P < 0.001).